Sign in

CIK 0001703057 · Large accelerated filer

AbCellera Biologics Inc.

Sign in to watch
Ticker
ABCL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(604) 559-9005
Business address
150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
Open-market buys, last 90 days
$1,379,662
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$1,379,662. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Thermopylae Holdings Ltd. +$699K 10% owner 1 filing
  2. Hayden Michael R +$570K Director 1 filing
  3. Montalbano John S. +$110K Director 1 filing
Date Insider Transaction Shares Price Value Owned after
2022-02-22 Hansen Carl L. G. Chief Executive Officer Option exercise +56,125 $2.70 $152K 280,625
2022-02-22 Hansen Carl L. G. Chief Executive Officer Option exercise · Share option (right to buy) −56,125 5,856,997
2021-12-10 Booth Andrew Chief Financial Officer Option exercise +500,000 $0.32 $160K 553,500
2021-12-10 Booth Andrew Chief Financial Officer Option exercise · Share Options (right to buy) −500,000 5,384,820
2021-12-08 Lecault Veronique Chief Operating Officer Option exercise +250,000 $0.19 $48K 1,589,333
2021-12-08 Lecault Veronique Chief Operating Officer Option exercise · Share Option (right to buy) −250,000 2,524,134
2021-12-07 Montalbano John S. Director Grant or award · Share option (right to buy) +45,532 579,814
2021-12-07 Hayden Michael R Director Grant or award · Share option (right to buy) +45,532 449,814
2021-12-07 Lecault Veronique Chief Operating Officer Grant or award · Share Option +406,020 2,930,154
2021-12-07 Hansen Carl L. G. Chief Executive Officer Grant or award · Share Option (right to buy) +920,312 5,913,122
2021-12-07 Booth Andrew Chief Financial Officer Grant or award · Share Option (right to buy) +406,020 5,884,820
2021-12-07 Stimart Tryn Chief Legal Officer Grant or award · Share Option (right to buy) +270,680 2,311,480
2021-12-03 Lo Andrew Director Grant or award · Share Option (right to buy) +91,325 91,325
2021-12-03 Lo Andrew Director Purchase +86,938 $14.02 $1.2M 86,938
2021-11-30 Lecault Veronique Chief Operating Officer Option exercise +83,333 $0.19 $16K 1,422,666
2021-11-30 Lecault Veronique Chief Operating Officer Option exercise · Share Option (right to buy) +83,333 2,774,134
2021-11-30 Lecault Veronique Chief Operating Officer Option exercise +83,333 $14.96 $1.2M 1,422,666
2021-11-30 Lecault Veronique Chief Operating Officer Option exercise · Share Option (right to buy) −83,333 2,774,134
2021-11-18 Hansen Carl L. G. Chief Executive Officer Option exercise +224,500 $15.03 $3.4M 224,500
2021-11-18 Hansen Carl L. G. Chief Executive Officer Option exercise · Share option (right to buy) −224,500 4,992,810

Page 6 of 11 · 203 trades